GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING Trademark

Trademark Overview


On Friday, January 17, 2025, a trademark application was filed for GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING with the United States Patent and Trademark Office. The USPTO has given the GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING trademark a serial number of 99008053. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 4, 2025. This trademark is owned by Insight Molecular Diagnostics Inc.. The GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in disease, condition and infection detection; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in in vitro diagnostic (IVD) testing

Medical testing for transplantation monitoring and transplantation therapy evaluation
graft assure dx decentralized transplant monitoring

General Information


Serial Number99008053
Word MarkGRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING
Filing DateFriday, January 17, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 25, 2025

Trademark Statements


Goods and ServicesMedical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in disease, condition and infection detection; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in in vitro diagnostic (IVD) testing
Goods and ServicesMedical testing for transplantation monitoring and transplantation therapy evaluation
Description of MarkThe mark consists of the wording "GRAFT ASSURE" in black, separated by a double helix design as part of the letter "A" in "ASSURE", followed by the word "DX" within a red square having a curved upper left and lower right corner, all stacked over the wording "DECENTRALIZED TRANSPLANT MONITORING" in smaller size font wherein "DECENTRALIZED" is in red, and "TRANSPLANT MONITORING" is in black. The color white in the mark is background and/or transparent area and is not claimed as a feature of the mark.
Indication of Colors claimedThe color(s) Black and Red is/are claimed as a feature of the mark.
NOT AVAILABLE"DECENTRALIZED TRANSPLANT MONITORING"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 17, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInsight Molecular Diagnostics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events


Event DateEvent Description
Friday, January 17, 2025NEW APPLICATION ENTERED
Sunday, March 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 30, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 31, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025NON-FINAL ACTION WRITTEN
Monday, March 31, 2025NON-FINAL ACTION E-MAILED
Monday, March 31, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 27, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, June 27, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, September 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 26, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 21, 2025WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, October 24, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, October 27, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, October 27, 2025EXAMINERS AMENDMENT E-MAILED
Monday, October 27, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 27, 2025EXAMINER'S AMENDMENT ENTERED
Monday, October 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER